Neonatal flecainide toxicity following supraventricular tachycardia treatment.
Hall
Catherine M
CM
Ward Platt
Martin P
MP
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004280:Dobutamine / Q000627:therapeutic use; D017335:Enoximone / Q000627:therapeutic use; D005260:Female; D005315:Fetal Diseases / Q000188:drug therapy; D005424:Flecainide / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D013617:Tachycardia, Supraventricular / Q000188:drug therapy* / Q000503:physiopathology
D000889:Anti-Arrhythmia Agents; D004280:Dobutamine; D017335:Enoximone; D005424:Flecainide